NEW YORK – Using a single-cell transcriptomic sequencing-based approach, a team from the US and Korea was able to narrow in on a promising treatment for a difficult-to-treat case of drug-induced hypersensitivity syndrome.
NEW YORK – Using a single-cell transcriptomic sequencing-based approach, a team from the US and Korea was able to narrow in on a promising treatment for a difficult-to-treat case of drug-induced hypersensitivity syndrome.
...and receive Daily News bulletins.
Already have a GenomeWeb or 360Dx account?
Login Now.
Don't have a GenomeWeb or 360Dx account?
Register for Free.
Privacy Policy. Terms & Conditions. . Copyright © 2021 GenomeWeb, a business unit of Crain Communications. All Rights Reserved.